AMGN Latest Headlines

Trump unveils 'Great Healthcare Plan' to lower drug prices, premiums

at seekingalpha.com (Thu, 15-Jan 11:38 AM)

Amgen Expands Sleep Apnea Pipeline With Phase 3 Trial of Maridebart Cafraglutide

at www.tipranks.com (Thu, 15-Jan 11:35 AM)

Amgen’s TEPEZZA Dosing Study Reaches Completion: What Investors Should Watch Next

at www.tipranks.com (Thu, 15-Jan 11:31 AM)

Amgen: Durable Growth from Core Franchises and High-Value MariTide Catalysts Support Buy Rating

at www.tipranks.com (Tue, 13-Jan 5:25 PM)

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Amgen (AMGN) and Annexon Biosciences (ANNX)

at www.tipranks.com (Tue, 13-Jan 1:00 PM)

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!

at www.tipranks.com (Tue, 13-Jan 10:37 AM)

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Henry Schein (HSIC) and NovoCure (NVCR)

at www.tipranks.com (Tue, 13-Jan 9:20 AM)

Amgen: Clinical Pipeline Momentum and Underappreciated Long-Term Growth Justify Buy Rating

at www.tipranks.com (Tue, 13-Jan 8:46 AM)

Scotiabank Keeps Their Buy Rating on Amgen (AMGN)

at www.tipranks.com (Tue, 13-Jan 7:36 AM)

Citi Sticks to Its Hold Rating for Amgen (AMGN)

at www.tipranks.com (Tue, 13-Jan 6:16 AM)

Amgen Expands Drug Discounts and Deepens U.S. Manufacturing Investments: Key Changes Ahead for Patients and Investors

Market Chameleon (Mon, 22-Dec 11:36 AM)

FDA Grants Full Approval to Amgen’s IMDELLTRA: Phase 3 Data Show 40% Reduced Risk of Death in Small Cell Lung Cancer

Market Chameleon (Thu, 20-Nov 8:24 AM)